Free shipping on all orders over $ 500

APVO603

Cat. No. M55255

All AbMole products are for research use only, cannot be used for human consumption.

APVO603 Structure
Synonym:

APVO-603

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

APVO603 is a dual agonist bispecific antibody employing a novel mechanism of action to simultaneously target 4-1BB (CD137) and OX40 (CD134), both members of the TNF-receptor family. Unlike chimeric antigen receptor T cell therapies (CAR-T) and bispecific CD3-based T cell engagers, APVO603 does not target a specific tumor antigen, thus allowing for broad potential therapeutic use for a number of different types of solid tumors. Since 4-1BB and OX40 are costimulatory receptors that are primarily expressed only T cells that have previously been exposed to tumor antigen, we believe APVO603 has the potential to cause less toxicity compared to traditional CD3-based T cell engagers due to its selectivity. Because APVO603 contains an Fc that does not interact with Fc gamma receptors, it has the potential to be less toxic than monospecific 4-1BB antibodies. While the activation of either 4-1BB or OX40 alone stimulates anti-tumor T cell responses, as a dual agonist bispecific antibody APVO603 has the potential to produce a synergistic or amplified response resulting in more robust T cell response.

Chemical Information
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Related TNF Receptor Products
Ozekibart

Ozekibart is an anti-TNFRSF10B monoclonal antibody.

TAPI-0 

TAPI-0 is a TACE (TNF-α converting enzyme; ADAM17) inhibitor with an IC50 of 100 nM.

Semapimod tetrahydrochloride

Semapimod tetrahydrochloride (CNI-1493), an inhibitor of proinflammatory cytokine production, can inhibit TNF-α, IL-1β, and IL-6.

BMS-566394

BMS-566394 is a potent, exceptionally selective inhibitor of TNF-α converting enzyme (TACE).

STAR-0310

STAR-0310 is a novel OX40 antagonistic monoclonal antibody which has a potential best-in-class profile with a high affinity, potential for favorable safety and tolerability profile with low T cell depletion from ADCC or possible on-target cellular toxicity.

  Catalog
Abmole Inhibitor Catalog




Keywords: APVO603, APVO-603 supplier, TNF Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.